MedPath

Effect of High Altitude Exposure, Acclimatization and Re-exposure on Cerebral Autoregulation in Lowlanders

Not Applicable
Completed
Conditions
Effect of High Altitude
Interventions
Other: altitude exposure
Registration Number
NCT02829255
Lead Sponsor
University of Zurich
Brief Summary

Prospective interventional trial in lowlanders evaluating the effect of acute exposure, acclimatization and re-exposure to high altitude on cerebral autoregulation

Detailed Description

Baseline measurements will be performed in Santiago de Chile, 520 m, over the course of 3 days. Participants will then travel by commercial airline (5 h flight) and by bus (3 h ride) to the ALMA base camp located at 2900 m near San Pedro de Atacama, northern Chile. Participants will stay there for the next 8 nights and they will be spend the days (6-8 h daily) at the telescope station at 5050 m while undergoing testing as described above at the first and the last day at 5050m. Daily transports from 2900 to 5050 m will be by car (1 h ride, one way). After the first 8 day altitude sojourn participants will return to the Santiago area (520 m) for a 6 day recovery period.

A second altitude sojourn with an identical schedule as the one described above and a final low altitude stay of 3 days will follow.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
21
Inclusion Criteria
  • Born, raised and currently living <800m
  • No overnight stay at altitudes >1500 m 4 weeks before the study
Read More
Exclusion Criteria
  • Previous altitude intolerance to altitude <3000 m
  • Pregnancy
  • Health impairment, which requires regular treatment
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Altitude exposurealtitude exposureAcute high altitude exposure followed by 8 day acclimatization and reexposure for 8 days after 6 days at low altitude
Primary Outcome Measures
NameTimeMethod
Coherence between middle cerebral artery blood flow velocity and systemic blood pressure as measure of cerebral autoregulation.day 1; day 2 first cycle

Change in magnitude of the coefficient of coherence between blood flow velocity in the middle cerebral artery measured by transcranial ultrasound Doppler and systemic blood pressure at day 2 (5050 m) vs. day 1 (520 m) of the first cycle

Secondary Outcome Measures
NameTimeMethod
Coherence between middle cerebral artery blood flow velocity and systemic blood pressure as measure of cerebral autoregulation.day 7 first cycle; day 7 second cycle

Change in magnitude of the coefficient of coherence between blood flow velocity in the middle cerebral artery measured by transcranial ultrasound Doppler and systemic blood pressure at day 7 (5050 m) second cycle vs. day 7 (5050 m) of the first cycle.

Trial Locations

Locations (1)

University of Zurich

🇨🇭

Zurich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath